StoneX maintains Buy rating on Rocket Companies, $16 price target

StoneX reduced its price target for Equity Bancshares (EQBK) to $58 from $59, citing net interest margin expectations. The firm raised its fiscal 2026 EPS forecast to $5.18 but lowered the 2027 estimate to $5.27. EQBK's stock trades at a P/E ratio of 10.58, and analysts expect net income growth. The company recently reported Q3 earnings beating estimates, with EPS of $1.40 vs. $1.29 expected, but revenue missed slightly.

StoneX initiated coverage of ON Semiconductor (ON) with a Buy rating, citing potential benefits from semiconductor demand recovery and growth in automotive and AI data center power systems. The stock is down 3% in premarket trading.

Onsemi (ON) guided Q3 revenue between $1.65B and $1.75B, up from $1.6B in Q2. StoneX initiated coverage with a bullish outlook, suggesting nearly 50% upside. Retail sentiment on Stocktwits is 'extremely bearish,' despite a 29% year-to-date rally for ON shares, compared to a 65% rise in the iShares Semiconductor ETF (SOXX).

StoneX maintained a Buy rating on Domino's Pizza (DPZ) with a $400 price target, implying a 35.1% upside from the Oct 13 close. The firm cited strong traffic growth drivers and attractive valuation relative to historical ranges. Recent analyst price targets for DPZ range from $320 to $425.

StoneX raised its price target for Securitize (NYSE: SECZ) to $18 from $12, citing its expansion into blockchain-based securities markets. The company launched a platform for trading tokenized U.S. stocks, including Apple, Nvidia, Microsoft, and Tesla. Securitize reported $4.3B in tokenized assets under management and $5.3B in transaction volume, but revenue declined 5% to $14.4M with a net loss of $21.7M.

Goldman Sachs upgraded Rocket Pharmaceuticals (RCKT) to Neutral, citing encouraging clinical updates on its gene therapy candidate RP-A501. The company remains unprofitable with no revenue, but its market cap of $284M reflects growth expectations. RCKT's GF Score is 35/100, showing mixed fundamentals. Insiders have sold shares, while some institutional investors hold positions.